Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In addition, some studies on recently marketed GLP-1 RAs such as dulaglutide (AWARD studies), albiglutide (HARMONY studies), and lixisenatide (GetGoal studies) included cardiovascular parameters as a part of their non-primary endpoints (Table 2)
Overall, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, AE profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities such as frailty [6, 22, 24]
de Wit, H
Dementia risk is complex, and GLP-1 therapy has risks, contraindications, and monitoring needs
,
US$ 26.63
US$ 28.79
US$ 29.38
US$ 23.14
US$ 26.95
US$ 28.45
US$ 20.11
US$ 29.77
US$ 20.48
US$ 27.63
US$ 26.74
US$ 25.75
US$ 20.94
US$ 23.63
US$ 24.96
US$ 29.82
US$ 21.22
